AptarGroup (ATR) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

AptarGroup

NYSE•Healthcare•Medical Instruments & Supplies

$124.44-1.06(-0.01%)Market closed

Market Cap

$7.92B

P/E

21.8x

P/S

2.0x

P/B

3.0x

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

How this company scores

AverageMetricSide Score: 59/100

Strongest: Cash & Earnings Quality (16/25); weakest: Balance Sheet & Red Flags (13/25).

Profitability15/25

Growth15/25

Balance Sheet & Red Flags13/25

Cash & Earnings Quality16/25

Strengths

Low leverageConsistent free cash flowConsistent growthImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 21.8x5y range 20.3x – 35.1x

Currently below its 20-quarter median.

P/S · 2.0x5y range 1.9x – 3.0x

Currently near its 20-quarter median.

P/B · 3.0x5y range 3.0x – 4.2x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Margin Pressure

Watch

Operating margins declined 15.0% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $7.92B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.93B
Q. Revenue: $1.03B
TTM EBITDA: $806.42M
TTM Op. Income: $477.42M
Q. Op. Income: $126.72M
TTM Net Income: $362.88M
Q. Net Income: $88.01M
EPS: $1.38
Shares Out.: $63.63M

$3.93B in TTM revenue grew 8.9% YoY, reaching $1.03B last quarter. TTM EBITDA of $806.42M and TTM operating income of $477.42M show growth is flowing through to the bottom line. TTM net income of $362.88M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 5 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 20.1%
Op. Margin: 12.3%
Net Margin: 8.6%

Op. margin of 12.3% is down 2.6% YoY — costs are rising relative to revenue. Net margin at 8.6% Over the past year, operating margin is down 17% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 21.8x
P/S Ratio: 2.0x
P/B Ratio: 3.0x

At 21.8x P/E, the stock trades within typical market levels. P/S of 2.0x and P/B of 3.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.13B
Cash: $190.40M
Long-Term Debt: $1.12B
Book Value: $2.63B
D/E Ratio: 0.4
Debt/EBITDA: 5.4

With $5.13B in assets and $1.12B in long-term debt, D/E is 0.4and book value is $2.63B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 115% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $103.49M
TTM Free Cash Flow: $310.39M
FCF Margin: 7.9%
FCF / Net Income: 0.9

TTM FCF of $310.39M on $103.49M in operating cash flow. The FCF / Net Income ratio of 0.9x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 15% — a weakening trend.